Merck Manual

Please confirm that you are a health care professional

Loading

Rickettsialpox

(Vesicular Rickettsiosis)

By

William A. Petri, Jr

, MD, PhD, University of Virginia School of Medicine

Last full review/revision Jul 2020| Content last modified Jul 2020
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

Rickettsialpox is caused by Rickettsia akari. Symptoms are an initial local lesion and a generalized papulovesicular rash.

Rickettsialpox, a rickettsial disease, occurs in many areas of the US and in Russia, Korea, and Africa. The vector, a small, colorless mite, is widely distributed. It infects the house mouse and some species of wild mice. Humans may be infected by chigger (mite larvae) or adult mite bites.

An eschar appears about 1 week before onset of fever as a small papule 1 to 1.5 cm in diameter, then develops into a small ulcer with a dark crust that leaves a scar when it heals. Regional lymphadenopathy is present. An intermittent fever lasts about 1 week, with chills, profuse sweating, headache, photophobia, and muscle pains. Early in the febrile course, a generalized maculopapular rash with intraepidermal vesicles appears, sparing the palms and soles.

The disease is mild; no deaths have been reported.

For details of diagnosis, see Diagnosis of Rickettsial and Related Infections.

Treatment is doxycycline 100 mg orally twice a day for 5 days or ciprofloxacin 750 mg orally twice a day for 5 days.

For prophylaxis, mouse harborages must be destroyed, and the vector controlled by residual insecticides.

Drugs Mentioned In This Article

Drug Name Select Trade
CILOXAN, CIPRO
PERIOSTAT, VIBRAMYCIN
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Overview of Lyme Disease
Video
Overview of Lyme Disease
3D Models
View All
SARS-CoV-2
3D Model
SARS-CoV-2

SOCIAL MEDIA

TOP